These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 27424208)

  • 21. Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.
    Li X; Liu J; Wang Y; Zhang L; Ning L; Feng Y
    Cancer Sci; 2009 Apr; 100(4):601-7. PubMed ID: 19453546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration.
    Patel M; Kawano T; Suzuki N; Hamakubo T; Karginov AV; Kozasa T
    Mol Pharmacol; 2014 Sep; 86(3):252-62. PubMed ID: 24958816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
    Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
    Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines.
    Kulasingam V; Diamandis EP
    Biol Chem; 2007 Oct; 388(10):1113-9. PubMed ID: 17937626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.
    Rasheed SAK; Leong HS; Lakshmanan M; Raju A; Dadlani D; Chong FT; Shannon NB; Rajarethinam R; Skanthakumar T; Tan EY; Hwang JSG; Lim KH; Tan DS; Ceppi P; Wang M; Tergaonkar V; Casey PJ; Iyer NG
    Oncogene; 2018 Mar; 37(10):1340-1353. PubMed ID: 29255247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).
    Malissein E; Meunier E; Lajoie-Mazenc I; Médale-Giamarchi C; Dalenc F; Doisneau-Sixou SF
    J Cancer Res Clin Oncol; 2013 Dec; 139(12):2079-88. PubMed ID: 24096540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion.
    Kim SR; Park HJ; Bae YH; Ahn SC; Wee HJ; Yun I; Jang HO; Bae MK; Bae SK
    Endocrinology; 2012 Feb; 153(2):554-63. PubMed ID: 22186408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrin stimulates pancreatic cancer cell directional migration by activating the Gα12/13-RhoA-ROCK signaling pathway.
    Mu G; Ding Q; Li H; Zhang L; Zhang L; He K; Wu L; Deng Y; Yang D; Wu L; Xu M; Zhou J; Yu H
    Exp Mol Med; 2018 May; 50(5):1-14. PubMed ID: 29717112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naturally occurring hotspot cancer mutations in Gα
    Maziarz M; Federico A; Zhao J; Dujmusic L; Zhao Z; Monti S; Varelas X; Garcia-Marcos M
    J Biol Chem; 2020 Dec; 295(49):16897-16904. PubMed ID: 33109615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific increase of human kallikrein 4 mRNA and protein levels in breast cancer stromal cells.
    Mangé A; Desmetz C; Berthes ML; Maudelonde T; Solassol J
    Biochem Biophys Res Commun; 2008 Oct; 375(1):107-12. PubMed ID: 18687310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
    Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues.
    Yousef GM; Chang A; Diamandis EP
    J Biol Chem; 2000 Apr; 275(16):11891-8. PubMed ID: 10766816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GNA13 as a prognostic factor and mediator of gastric cancer progression.
    Zhang JX; Yun M; Xu Y; Chen JW; Weng HW; Zheng ZS; Chen C; Xie D; Ye S
    Oncotarget; 2016 Jan; 7(4):4414-27. PubMed ID: 26735177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
    Ehrenfeld P; Manso L; Pavicic MF; Matus CE; Borquez C; Lizama A; Sarmiento J; Poblete MT; Bhoola KD; Naran A; Figueroa CD
    Anticancer Res; 2014 Dec; 34(12):6925-38. PubMed ID: 25503118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G(alpha)12-mediated pathway promotes invasiveness of nasopharyngeal carcinoma by modulating actin cytoskeleton reorganization.
    Liu SC; Jen YM; Jiang SS; Chang JL; Hsiung CA; Wang CH; Juang JL
    Cancer Res; 2009 Aug; 69(15):6122-30. PubMed ID: 19602597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Blk-p190RhoGAP signaling module downstream of activated Gα13 functionally opposes CXCL12-stimulated RhoA activation and cell invasion.
    Bartolomé RA; Díaz-Martínez M; Coló GP; Arellano-Sánchez N; Torres-Ayuso P; Kleinovink JW; Mérida I; Teixidó J
    Cell Signal; 2014 Nov; 26(11):2551-61. PubMed ID: 25025568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
    Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA
    Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
    Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
    Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ARHGAP18 Downregulation by miR-200b Suppresses Metastasis of Triple-Negative Breast Cancer by Enhancing Activation of RhoA.
    Humphries B; Wang Z; Li Y; Jhan JR; Jiang Y; Yang C
    Cancer Res; 2017 Aug; 77(15):4051-4064. PubMed ID: 28619708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.